1. Home
  2. SEB vs NAMS Comparison

SEB vs NAMS Comparison

Compare SEB & NAMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Seaboard Corporation

SEB

Seaboard Corporation

HOLD

Current Price

$4,647.73

Market Cap

4.9B

Sector

Industrials

ML Signal

HOLD

Logo NewAmsterdam Pharma Company N.V.

NAMS

NewAmsterdam Pharma Company N.V.

HOLD

Current Price

$34.26

Market Cap

4.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SEB
NAMS
Founded
1918
2019
Country
United States
Netherlands
Employees
N/A
100
Industry
Farming/Seeds/Milling
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.9B
4.6B
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
SEB
NAMS
Price
$4,647.73
$34.26
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
$46.75
AVG Volume (30 Days)
5.7K
1.4M
Earning Date
05-12-2026
05-06-2026
Dividend Yield
0.17%
N/A
EPS Growth
467.71
N/A
EPS
124.24
N/A
Revenue
$5,809,000,000.00
N/A
Revenue This Year
N/A
$17.96
Revenue Next Year
N/A
$540.65
P/E Ratio
$37.53
N/A
Revenue Growth
7.99
N/A
52 Week Low
$2,446.37
$16.79
52 Week High
$5,989.37
$42.21

Technical Indicators

Market Signals
Indicator
SEB
NAMS
Relative Strength Index (RSI) 33.59 51.22
Support Level $4,258.94 $34.05
Resistance Level $4,800.00 $37.25
Average True Range (ATR) 262.03 2.29
MACD -76.04 0.36
Stochastic Oscillator 24.04 43.17

Price Performance

Historical Comparison
SEB
NAMS

About SEB Seaboard Corporation

Seaboard Corp is a diversified group of companies that operate in agricultural, energy, and ocean transport businesses. The company is engaged in hog production, biofuel production, and pork processing in the United States; commodity trading and grain processing in Africa and South America; cargo shipping services in the U.S., Caribbean and Central and South America; sugar and alcohol production in Argentina; and electric power generation in the Dominican Republic. It also has an equity method investment in Butterball, LLC, a producer and processor of turkey products. The group's operating segments are; pork, commodity trading and milling, marine, liquid fuels, power, turkey, and others. It operates in 45 countries, with a concentration in the Caribbean, Central and South American region.

About NAMS NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments. The Company has one reportable segment, which comprises the discovery, development, and commercialization of transformative therapies for cardio-metabolic diseases.

Share on Social Networks: